Africa has seen a 425% increase in the number of dermatology trials taking place over the past decade, the largest increase for any region worldwide.

The region now ranks in first for the total number of trials taking place, compared to its second placed ranking in 2010.

These figures come from GlobalData ‘s extensive clinical trials database which seeks to track the number of clinical trials taking place in countries around the world, in numerous therapy areas.

Africa

Africa saw the biggest increase in dermatology-related trials.

Between 2010 and 2020, there was a 425% increase in the number of trials taking place.

In 2020, the largest proportion of trials in the region took place in Egypt with 76.2% of all trials in the region taking place there.

South Africa and Kenya had the next largest percentage of trials taking place in the region with 9.5% and 4.8%, respectively.

Asia-Pacific

The Asia-Pacific region saw a 240% increase in the number of dermatology trials taking place.

China saw the largest amount of trials taking place, in 2020, at 38.7%.

Trials in India and Japan also made up a large proportion of the trials taking place with 21.1% and 11.4%, respectively.

Europe

Europe saw a 110% increase in the number trials taking place.

Germany, France and Poland made up the most trials in the region, with 14.5%, 9.2% and 7.6%, respectively.

Middle East

The Middle East saw a 110% increase in dermatology-related trials taking place.

Iran saw the largest percentage of trials taking place in the region at 84.5%.

Israel and Lebanon also made up a significant proportion of the trials taking place.

North America

Despite being placed fifth, North America still saw an increase in the number of dermatology trials.

The region saw a 52% increase in the number of trials.

The United States made up 77% the largest proportion of trials taking place in the region.

Canada and Mexico also made up a large amount of the trials taking place with 20.4% and 2.6%, respectively.

South and Central America

South and Central America saw the biggest decrease in dermatology trials.

The number of trials in the region fell by 6% between 2010 and 2020.

Brazil saw the largest percentage of trials taking place in the region with 36.8%.